Physician

Ndegwa M. Njuguna, M.D.

According to 2025 Medicare claims, Ndegwa Njuguna, M.D. (NPI: 1851577522) practices hematology/oncology in the Tacoma-Lakewood, WA market, with the plurality of this provider's patient population coming from Pierce, WA. This provider's primary affiliated billing organization is NORTHWEST MEDICAL SPECIALTIES PLLC (NPI: 1548261308; TIN: 911867315) and primary practice location at 98405-5093. Njuguna is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Njuguna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 620 traditional Medicare patients, billed 220,268 HCPCS/CPT codes, and received $3,243,272 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 305 prescription claims across 91 beneficiaries totaling $844,691 in drug costs, led by Lenalidomide (Lenalidomide). 2021 DME data shows 11 claims. Open Payments data shows 22 records totaling $28,301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,979,828 and ending at $3,243,272. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $228,449 and ending at $844,691. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	745	242,819	$1,979,828
2016	829	262,569	$2,029,891
2017	887	219,257	$2,582,229
2018	1,099	216,028	$1,998,777
2019	869	349,526	$2,598,306
2020	813	199,299	$2,973,569
2021	691	121,798	$2,030,841
2022	495	88,128	$1,550,098
2023	522	114,617	$2,103,053
2024	620	220,268	$3,243,272

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	98	558	$228,449
2016	114	651	$533,509
2017	127	716	$1,480,142
2018	108	454	$1,148,595
2019	121	402	$251,514
2020	123	542	$1,301,397
2021	101	509	$1,315,547
2022	93	556	$2,264,766
2023	82	340	$1,559,300
2024	91	305	$844,691

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	61	$27,259
2016	N/R	N/R	N/R
2017	N/R	14	$5,506
2018	N/R	91	$4,780
2019	N/R	N/R	N/R
2020	N/R	62	$3,573
2021	N/R	11	$1,681
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	119	458	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	197	318	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	164	311	$13
36415	Insertion of needle into vein for collection of blood sample	195	565	$8
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	128	219	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	18	504	$150,639
Abiraterone Acetate	Abiraterone Acetate	39	1,350	$34,048
Hydroxyurea	Hydroxyurea	21	918	$638
Prochlorperazine Maleate	Prochlorperazine Maleate	25	314	$323
Prednisone	Prednisone	15	441	$48

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$496	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$27,805	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ndegwa M. Njuguna, M.D.?

Tedicare shows public-source Medicare data for Ndegwa M. Njuguna, M.D. (NPI 1851577522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ndegwa M. Njuguna, M.D. have ACO affiliation data?

Ndegwa M. Njuguna, M.D. is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Ndegwa M. Njuguna, M.D.?

Ndegwa M. Njuguna, M.D. is linked to NORTHWEST MEDICAL SPECIALTIES PLLC (billing NPI 1548261308) in the available physician profile data.

Does Ndegwa M. Njuguna, M.D. have Open Payments data?

Ndegwa M. Njuguna, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.